Soligenix Inc (NASDAQ:SNGX)

2.30
Delayed Data
As of Aug 10
 +0.04 / +1.77%
Today’s Change
0.85
Today|||52-Week Range
3.54
+58.62%
Year-to-Date
Soligenix files for $50M shelf offering
Jul 31 / Seeking Alpha - Paid Partner Content
Soligenix: Multiple Shots On Goal, Strong Evidence Of Success, And Attractive Valuation
Jul 28 / Seeking Alpha - Paid Partner Content
Sonoma Pharmaceuticals leads healthcare gainers; Aphria and Soligenix among losers
Jul 29 / Seeking Alpha - Paid Partner Content
TCOM, PII among premarket gainers
Jul 28 / Seeking Alpha - Paid Partner Content
STX, BCS among premarket losers
Jul 29 / Seeking Alpha - Paid Partner Content
Soligenix rallies on encouraging data on COVID-19 vaccine
Jul 28 / Seeking Alpha - Paid Partner Content

Today’s Trading

Previous close2.26
Today’s open2.21
Day’s range2.16 - 2.35
Volume12,895
Average volume (3 months)1,389,246
Market cap$59.0M
Data as of 3:59pm ET, 08/10/2020

Growth & Valuation

Earnings growth (last year)+28.52%
Earnings growth (this year)-36.46%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-18.91%
P/E ratioNM
Price/Sales8.74
Price/Book33.14

Competitors

 Today’s
change
Today’s
% change
PTEPolarityTE Inc+0.02+1.32%
VBLTVascular Biogenics L...+0.01+0.77%
ASLNAslan Pharmaceutical...0.000.00%
AKTXAkari Therapeutics P...+0.10+5.24%
Data as of 3:59pm ET, 08/10/2020

Financials

Last reporting dateAugust 10, 2020
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$3.2M
Annual profit (last year)-$9.4M
Net profit margin-290.94%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Princeton, New Jersey

Forecasts